Repositioning Candidate Details
| Candidate ID: | R0877 |
| Source ID: | DB05810 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | 99mTc-glucarate |
| Synonyms: | -- |
| Molecular Formula: | -- |
| SMILES: | -- |
| DrugBank Description: | 99mTc-glucarate(GLA) is an agent for non-invasive detection of breast tumours. |
| CAS Number: | -- |
| Molecular Weight: | |
| DrugBank Indication: | Investigated for use/treatment in myocardial infarction. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | 99m Tc-Glucarate marks acute myocardial infarct very early after occlusion and appears to accurately assess infarct size when compared with triphenyltetrazolium chloride (TTC) staining. |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I08 | 114 | Cardiovascular system disease | A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis. http://en.wikipedia.org/wiki/Circulatory_system | disease of anatomical entity | Details |